LaViscount Joyce N 4
4 · HELIUS MEDICAL TECHNOLOGIES, INC. · Filed Apr 5, 2021
Insider Transaction Report
Form 4
LaViscount Joyce N
Director
Transactions
- Award
Class A Common Stock
2021-04-01+5,337→ 9,576 total - Award
Employee Stock Option (Right to Buy)
2021-04-01+3,490→ 3,490 totalExercise: $17.80Exp: 2031-04-01→ Class A Common Stock (3,490 underlying) - Award
Class A Common Stock
2021-04-01+2,668→ 12,244 total
Footnotes (3)
- [F1]Grant to the Reporting Person of a stock award under the Issuer's 2018 Omnibus Incentive Plan.
- [F2]Grant to the Reporting Person of Restricted Stock Units under the Issuer's 2018 Omnibus Incentive Plan. The shares will vest on October 2, 2021.
- [F3]Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of four (4) successive equal annual installments beginning on April 1, 2022.